A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer

Beijing Cancer Hospital, Beijing

Liaoning Cancer Hospital and Institute, Shenyang

Harbin Medical University Cancer Hospital, Harbin

Fudan University Shanghai Cancer Center, Shanghai

Affiliated Zhongshan Hospital of Fudan University, Shanghai

Shanghai East Hospital Branch Hospital, Shanghai

General Hospital of Eastern Theatre Command Qihuaiyuan Branch(the St Hospital of Chinese Pla), Nanjing

The Second Hospital of Anhui Medical University, Hefei

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

Fujian Medical University Union Hospital, Fuzhou

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Zhongnan Hospital of Wuhan University Wuhan, Wuhan

Hubei Cancer Hospital, Wuhan

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou

Nanfang Hospital of Southern Medical University, Guangzhou